- Home
- FLWS vs CRVS Comparison
FLWS vs CRVS Comparison
Compare FLWS & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- CRVS
- Stock Information
- Founded
- FLWS 1976
- CRVS 2014
- Country
- FLWS United States
- CRVS United States
- Employees
- FLWS N/A
- CRVS N/A
- Industry
- FLWS Other Specialty Stores
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- FLWS Consumer Discretionary
- CRVS Health Care
- Exchange
- FLWS Nasdaq
- CRVS Nasdaq
- Market Cap
- FLWS 327.4M
- CRVS 305.4M
- IPO Year
- FLWS 1999
- CRVS 2016
- Fundamental
- Price
- FLWS $5.38
- CRVS $4.10
- Analyst Decision
- FLWS Hold
- CRVS Strong Buy
- Analyst Count
- FLWS 1
- CRVS 4
- Target Price
- FLWS $7.50
- CRVS $15.00
- AVG Volume (30 Days)
- FLWS 929.0K
- CRVS 466.9K
- Earning Date
- FLWS 08-28-2025
- CRVS 08-12-2025
- Dividend Yield
- FLWS N/A
- CRVS N/A
- EPS Growth
- FLWS N/A
- CRVS N/A
- EPS
- FLWS N/A
- CRVS N/A
- Revenue
- FLWS $1,709,948,000.00
- CRVS N/A
- Revenue This Year
- FLWS N/A
- CRVS N/A
- Revenue Next Year
- FLWS N/A
- CRVS N/A
- P/E Ratio
- FLWS N/A
- CRVS N/A
- Revenue Growth
- FLWS N/A
- CRVS N/A
- 52 Week Low
- FLWS $3.86
- CRVS $2.47
- 52 Week High
- FLWS $10.42
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- FLWS 44.99
- CRVS 44.93
- Support Level
- FLWS $6.04
- CRVS $4.58
- Resistance Level
- FLWS $6.99
- CRVS $4.98
- Average True Range (ATR)
- FLWS 0.59
- CRVS 0.23
- MACD
- FLWS -0.05
- CRVS -0.04
- Stochastic Oscillator
- FLWS 7.55
- CRVS 13.79
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).